Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease by Smart Angioplasty Research Team: SMART-ROAD Trial

NCT02516826 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02516826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02516826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease by Smart Angioplasty Research Team: SMART-ROAD Trial
Lead sponsor
Samsung Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2015
Completion date
August 31, 2018
Enrollment
504 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary syndrome